Покровский А. В., Догужиева Р. М.
Отделение хирургии сосудов Института хирургии им. А. В. Вишневского Федерального агентства высокотехнологичной медицинской помощи
Москва, 115093, Москва, ул. Б. Серпуховская, д. 27. E-mail: drmv@mail.ru

Значение гипергомоцистеинемии при сосудистых заболеваниях 

ЛИТЕРАТУРА
1. Костюченко, Г. И. Диагностика и методы коррекции гипергомоцистеинемии в кардиологической практике: пособие для врачей / Г. И. Костюченко, З. С. Баркаган. – М., 2003.
2. Хубутия, М. Ш. Гомоцистеин при коронарной болезни сердца и сердечного трансплантата / М. Ш. Хубутия, О. П. Шевченко. – М., 2004. – С. 39.
3. Шевченко, О. П. Гипергомоцистеинемия и ее клиническое значение / О. П. Шевченко, Г. А. Олефриенко // Лаборатория. – 2002, № 1. – С. 3–7.
4. Arnesen, E. Serum total homocysteine and coronary heart disease / E. Arnesen, H. Refsum, K. H. Bonaa et al. // Int. J. Epidemiol. – 1995. – Vol. 24. – P. 704–709.
5. Bonaa, K. H. NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction / K. H. Bonaa, I. Njolstad, P. M. Ueland et al. // N. Engl. J. Med. – 2006. –Vol. 354, № 15. – P. 1578–1588.
6. Bots, M. L. Homocysteine and short term risk of myocardial infarction and stroke in the elderly / M. L. Bots, L. J. Launer, J. Lindemans // Arch. Intern. Med. – 1999. – Vol. 159. – P. 38–44.
7. Boushey, C. J. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease / C. J. Boushey, S. A. A. Beresford, G. S. Omenn, A. G. Motulsky // JAMA. – 1995. – Vol. 274. – P. 1049–1057.
8. Brattstrom, L. E. Homocysteine and cardiovascular disease; caus or effect? / L. E. Brattstrom, D. E. L. Wilcken // Am. J. Clin. Nutr. – 2000. – Vol. 72. – P. 315–323.
9. Fu, W. Homocysteinemia attenuates hemodynamic responses to nitric oxide in vivo / W. Fu, N. Dudman, M. Perry, X. Wang // Atherosclerosis. – 2002. – Vol. 161, № 1. – P. 169–176.
10. Graham, I. M. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project / I. M. Graham, L. E. Daly, H. Refsum et al. // JAMA. – 1989. – Vol. 261. – P. 1775–1781.
11. Hansrani, M. Homocysteine in myointimal hyperplasia / M. Hansrani, J. Gillespie, G. Stansby // Eur. J. Vasc. Endovasc. Surg. – 2002. – Vol. 23. – P. 3–10.
12. Hillenbrand, R. Hyperhomocysteinemia and recurrent carotid stenosis / R. Hillenbrand, A. Hillenbrand, F. Liewald et al. // BMC Cardiovasc. Disprd. – 2008. – Vol. 8. – P. 1.
13. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis // JAMA. – 2002. – Vol. 288. – P. 2015–2022.
14. Jacques, P. F. Serum total homocysteine concentrations in adolescent and adult Americans results from the third National Health and Nutrition Elamination Survey / P. F. Jacques, I. H. Rosenberg, G. Rogers et al. // Am. J. Clin. Nutr. – 1999. – Vol. 69. – P. 482–489.
15. Kothekar, M. A. Homocysteine in cardiovascular disease: a culprit or an innocent bystander?/ M. A. Kothekar // Indian J. Mtd. Sci. – 2007. – Vol. 61, № 6. – P. 361–371. 16. Lonn, E. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine Lowering with folic acid and B vitamins in vascular disease / E. Lonn, S. Yusuf, M. J. Arnold et al. // N. Engl. J. Med. – 2006. – Vol. 354, № 15. – P. 1567–1577.
17. Loscalo, J. The oxidant stress of hyperhomocysteinemia / J. Loscalo // J. Clin. Invest. – 1996. – Vol. 98, № 1. – P. 5–7.
18. Malinow, M. R. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study / M. R. Malinow, F. J. Nieto, M. Szklo et al. // Circulation. – 1993. – Vol. 87. – P. 1107–1113.
19. Malinow, M. R. Homocysteine diet and cardiovascular diseases. A statement for Health Professionals from Nutrition Committee, American Heart Association // M. R. Malinow, A. G. Bostom, R. M. Krauss // Circulation. – 1999. – Vol. 99. – P. 178–182.
20. Mayer, E. Homocysteine and coronary atherosclerosis / E. Mayer, D. Jacobsen, K. Robinson // Am. J. Pathol. – 1969. – Vol. 56. – P. 111–128.
21. Nygard, O. Plasma homocysteine levels and mortality in hatients with coronary artery disease / O. Nygard, J. E. Norderhaug, H. Refsum et al. // N. Engl. J. Med. – 1997. – Vol. 337. – P. 230–236.
22. Quinlivan, E. P. Homocysteine B vitamins and cardiovascular disease / E. P. Quinlivan, J. F. Gregjry // N. Engl. J. Med. – 2006. – Vol. 355. – P. 207.
23. Rassmusen, K. Age-and gende-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation / K. Rassmusen, J. Moller, M. Lyngbak et al. // Clin. Chemistry. – 1996. – Vol. 42. – P. 630–636.
24. Refsum, H. Homocysteine B vitamins and cfrdiovascular disease / H. Refsum, A. D. Smith // N. Engl. J. Med. – 2006. – Vol. 355. – P. 1567–1577.
25. Spence, J. D. Vitamin Intervention For Stroke Prevention trial: an efficacy analysis / J. D. Spence, H. Bang, L. E. Chambless et al. // Stroke. – 2005. – Vol. 36, № 11. – P. 2404–2409.
26. Stampfer, M. J. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians / M. J. Stampfer, M. R. Malinow, W. C. Willett et al. // JAMA. – 1992. – Vol. 268, № 7. – P. 877–881.
27. Stein, J. Hyperhomocysteinemia and atherosclerotic vascular disease / J. Stein, P. Mc Bride // Arch. Intern. Med. – 1998. – Vol. 158. – P. 1301–1306.
28. Tsai, M. Y. Plasma Homocysteine and its association with carotid intimal-medial thickness and prevalent coronary heart disease: NHLBI Famaly Heart Stady / M. Y. Tsai, D. K. Arnett, J. H. Eckfeldt et al. // Atherosclerosis. – 2000. – Vol. 151. – P. 519–524.
29. Ueland, P. M. The controversy over homocysteine and cardiovascular risk / P. M. Ueland, H. Refsum, S. A. Beresford et al. // Am. J. Clin. Nutr. – 2000. – Vol. 72. – P. 324–332.
30. Wald, N. J. Homocysteine and ischemic heart disease / N. J. Wald, H. C. Watt, M. R. Law et al. // Arch. Intern. Med. – 1998. – Vol. 158. – P. 862–867.
31. Warren, C. Emergem cardiovascular risk factor: Homocysteine / C. Warren // Prog. Cardiovasc. Nurs. – 2002. – Vol. 17. – P. 35–41.
32. Welch, G. Homocysteine and atherosclerosis / G. Welch, J. Loscalo // New Engl. J. Med. – 1998. – Vol. 338, № 15. – P. 1042–1050.
33. Welch, G. Hyperhomocyst(e)inemia and atherothrombosis / G. Welch, G. Upchurch, J. Loscalo // Ann. N.Y. Acad. Sci. – 1997. – Vol. 811. – P. 48–58.
34. Wilcken, D. E. L. The pathogenesis of caronary artery disease. A possible role for methionine metabolism / D. E. L. Wilcken, B. Wilcken // J. Clin. Invest. – 1976. – Vol. 57. – P. 1079–1082.